LAB260515P00002000 Option on Standard Biotools

LAB Stock  USD 1.26  0.02  1.56%   
LAB260515P00002000 is a PUT option contract on Standard Biotools' common stock with a strick price of 2.0 expiring on 2026-05-15. The contract was not traded in recent days and, as of today, has 99 days remaining before the expiration. The option is currently trading at a bid price of $0.3, and an ask price of $1.05. The implied volatility as of the 5th of February is 99.0.
A put option written on Standard Biotools becomes more valuable as the price of Standard Biotools drops. Conversely, Standard Biotools' put option loses its value as Standard Stock rises.

Rule 16 of 2026-05-15 Option Contract

The options market is anticipating that Standard Biotools will have an average daily up or down price movement of about 0.0% per day over the life of the option. With Standard Biotools trading at USD 1.26, that is roughly USD 0.0. If you think that the market is fully understating Standard Biotools' daily price movement you should consider buying Standard Biotools options at that current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

In The Money Put Option on Standard Biotools

An 'In The Money' option is one with a strike price that the current stock price has already surpassed. Some options investors can hedge their Standard Biotools positions using in-the-money options. They may also want to buy options with some intrinsic value, not just time value. However, because in-the-money options on Standard Stock have intrinsic value and are priced higher than out-of-the-money options in the same chain, their volatilities are relatively smaller.
Put Contract NameLAB260515P00002000
Expires On2026-05-15
Days Before Expriration99
Open Interest13
Strike Price2.0
Last Traded At0.77
Current Price Spread0.3 | 1.05

Standard long PUT Option Payoff at expiration

Put options written on Standard Biotools grant holders of the option the right to sell a specified amount of Standard Biotools at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Standard Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Standard Biotools is like buying insurance aginst Standard Biotools' downside shift.
   Profit   
       Standard Biotools Price At Expiration  

Standard short PUT Option Payoff at expiration

By selling Standard Biotools' put option, the investors signal their bearish sentiment. A short position in a put option written on Standard Biotools will generally make money when the underlying price is above the strike price. Therefore Standard Biotools' put payoff at expiration depends on where the Standard Stock price is relative to the put option strike price. The breakeven price of 2.0 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Standard Biotools' price. Finally, at the strike price of 2.0, the payoff chart is constant and positive.
   Profit   
       Standard Biotools Price At Expiration  
View All Standard Biotools Options

Standard Biotools Available Put Options

Standard Biotools' option chain is a display of a range of information that helps investors for ways to trade options on Standard. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Standard. It also shows strike prices and maturity days for a Standard Biotools against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
 Put
LAB260515P0000050000.50.0 - 0.250.25Out
 Put
LAB260515P0000100011.00.0 - 0.750.05Out
 Put
LAB260515P0000150011.50.0 - 0.750.25In
 Put
LAB260515P00002000132.00.3 - 1.050.77In
 Put
LAB260515P0000250002.50.8 - 1.550.8In
 Put
LAB260515P0000500005.03.1 - 4.33.1In
 Put
LAB260515P0000750007.55.4 - 6.95.4In

Standard Biotools Corporate Management

Jeffrey BlackChief OfficerProfile
Shane BowenChief OfficerProfile
Elizabeth JensenChief OfficerProfile
Mark SpearmanSr CommunicationsProfile
Mike MusgnugSenior OfficerProfile
John GrazianoVice RelationsProfile
When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. Expected growth trajectory for Standard significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Standard Biotools assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.37)
Revenue Per Share
0.448
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.15)
Return On Equity
(0.33)
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Standard Biotools' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Standard Biotools represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Standard Biotools' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.